Results 191 to 200 of about 133,012 (307)

Understanding the factors influencing antipsychotic medication use in continuing care during the COVID-19 pandemic: a qualitative descriptive study. [PDF]

BMJ Open
Karimi-Dehkordi M, Asaana P, Wagg A, Hanson HM, Harasym P.   +4 more
europepmc   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Adjunctive xanomeline/trospium in clozapine-resistant schizophrenia: two case reports demonstrating limited response. [PDF]

Ther Adv Psychopharmacol
Dang VM, Powers JM, Markota M, Leung JG.
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Development and validation of a precision treatment rules for first-line antipsychotic recommendations in first episode psychosis jointly incorporating effectiveness, side effects and patient preferences. [PDF]

Transl Psychiatry
Krakowski K, Oliver D, Arribas M, Logeswaran Y, de Micheli A, Patel R, Stahl D, Fusar-Poli P.   +7 more
europepmc   +1 more source

Financing of mental health in Estonia [PDF]

, 2003
Habicht, Triin, Thetloff, Maie
core  

Human health benefit and burden of the schizophrenia health care pathway in Belgium : paliperidone palmitate long-acting injections [PDF]

, 2019
De Smedt, Delphine, Debaveye, Sam, Dewulf, Jo, Heirman, Bert, Kavanagh, Shane   +4 more
core   +1 more source

The association between new-use of antipsychotics and all-cause mortality in a cohort of patients with dementia in Argentina. [PDF]

PLOS Ment Health
Vivacqua MN, Osores PI, Brienza H, Barrera T, Faccioli JL, Ferraris A.   +5 more
europepmc   +1 more source

The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Prescription opioid‐related harm remains a significant public health concern. This study aimed to evaluate the efficacy of the Opioid Safety Toolkit, a co‐designed, interactive online resource, in increasing naloxone uptake and healthcare provider discussions among adults prescribed opioids for pain.
Suzanne Nielsen, Frederick Fox, Tina Lam, Alex Waddell, Monica Jung, Bosco Rowland, Jessica Watterson, Dhruv Basur, Chris Prawira, Joshua Paolo Seguin, Patrick Olivier, Jarrod McMaugh, Paul Dietze, Louisa Picco   +13 more
wiley   +1 more source

Corrigendum to "Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis". [PDF]

Ther Adv Psychopharmacol
europepmc   +1 more source